derived from protocol
has knowledgeable contact person
uses biomaterial
Datasets  >  clinical study dataset  >  50 patient phase II clinica...

50 patient phase II clinical trial for melanoma

clinical study dataset

Our lead product for the treatment of cancer is OncoVex GMCSF. OncoVexGMCSF is completing a 50-patient Phase II clinical trial for the treatment of unresectable metastatic melanoma, as a monotherapy, in the second line/salvage therapy setting. Data so far indicates that OncoVex can destroy both injected and un-injected melanoma deposits. The trial is still in progress.

created over 14 years ago (2 March 2009)    last modified over 4 years ago (21 February 2019)   [ RDF Rdf ]   [ RelFinder Relfinder ]